Picture of Tefferi Poster at ASCO by Ruben Mesa

[Fishermangents]

Taken from Mesa's Twitter Blog:

https://pbs.twimg.com/media/CkRUFaqWgAEAc_B.jpg

From the photo:

Status:
- Approximately 97 sites are planned in 12 countries
- Enrollment began in June 2015 and is ongoing
- As of May 25, 2016, there are 77 active sites

[biopearl]

Actually you can see the real thing on the Geron home page. Click investor relations, past events and you can access the poster. 77 active and 97 planned is good news. I am trying to get a read on what might come at ASH. Clearly they plan for 200 patients but the study can be terminated early at the behest of the sponsor. Since the primary end point is assessed at 24 weeks (!!) I continue to maintain that the study is designed to stop early. Once we see if patients cross over to the higher (or lower dose)--remember John was on 7.5 halfway between the two arms, we might get more clarity. With 77 sites active, it is reasonable to guess that between 70 and 100 patients are already enrolled. With 20 more sites planned they should be at 200 enrolled by the end of the year. The question is what will be ready to be presented at ASH. Dr. T's pilot study (80 its) is completed so maybe this will provide the foundation for 2016 ASH presentations. What would be dramatic is if the data from the ongoing Jannsen study compels early conclusions and data that could be presented maybe as a late breaker at ASH 2016. If not the long wait continues but so many anticipated study sites speaks well for Janssen's commitment based on what they must be seeing and a desire to move faster. I have a little spring in my step today that has been sorely lacking for a while. Best wishes to all and especially John wherever he might be. bp

[hiprock88]

Thanks Bio. I think we can be reasonably confident John is still on the 7.5 dosage.

[Fishermangents]

So the Geron website is updated after all! Here is the link:

http://phx.corporate-ir.net/External.Fi ... 02MzY3Mzk=

(also on imetelstat.info under 'clinical' tab)